Dr. Prof Suresh H Advani

Dr. Prof Suresh H Advani

Senior Consultant 

55 Years of Experience

Medical Oncologist

MBBS, MD, Fellowship, FICP, MNAMS, FNAMS

Nanavati-Max Super Speciality Hospital, Mumbai

English

Consultation Fee ₹ 1500

Book an Appointment

About Dr. Prof Suresh H Advani

  • Dr. Suresh H. Advani is an eminent Medical oncologist in Mumbai.
  • He has over 55 years of clinical experience and is credited as the pioneer of Bone Marrow Transplantation in India.
  • Dr. Suresh Advani has received prestigious awards such as the Padma Shri, Padma Bhushan, and the Dhanvantari Award for his outstanding contributions to medicine and oncology.
  • He holds the distinction of being the first oncologist in India to perform a bone marrow transplant successfully.
  • Dr. Advani specializes in the management of cancers of the breast, blood, head & neck, cervix, lungs, colon, prostate, and stomach. 
  • He completed his MBBS from Grand Medical College & Sir J.J Group of Hospitals, Mumbai, in 1969, followed by an MD in General Medicine from the Bombay University, Mumbai, in 1973.
  • Later, he gained expertise in bone marrow transplantation from the Fred Hutchinson Cancer Research Center in Seattle, USA.
  • Dr. Advani's other qualifications include a Fellowship of the Indian College of Pathologists (FICP) in 1992, a Member of the National Academy of Medical Sciences (MNAMS) in 1995, and a Fellowship of the National Academy of Medical Sciences (FNAMS) in 1996.
  • His research contributions include approximately 648 national and international publications.
  • Dr. Advani was pivotal in establishing the DM (Medical Oncology) program at Tata Memorial Hospital.
  • He serves as a guide for M.Sc. and Ph.D. students in Applied Biology. 
  • As Chief Investigator, he has led projects on leukemia supported by prestigious institutions like the National Cancer Institute and the Department of Science and Technology.
  • Dr. Advani is actively involved in developing the DM (Medical Oncology) Course curriculum in collaboration with the Indian Medical and Pediatric Oncology Association.
  • He is focused on breast cancer and is leading initiatives such as mobile mammography projects for early diagnosis and multinational clinical trials.
  • He has significantly contributed to biological therapeutics targeting molecular targets on cancer cells.
     

Book Your Appointment With Dr. Prof Suresh H Advani

Get a Treatment Plan Within 1 Hour

Education

  • MBBS - Grand Medical College & Sir J.J Group of Hospitals, Mumbai, 1969
  • MD (General Medicine) - Bombay University, Mumbai, 1973
  • Fellowship of Yamagiwa-Yoshida Memorial International Cancer Study Grant of the International Union Against Cancer (UICC), 1986
  • Fellowship of the Indian College of Pathologists (FICP), 1992
  • Member of National Academy of Medical Sciences (MNAMS,) 1995
  • Fellow of National Academy of Medical Sciences (FNAMS), 1996

Training & Certificates

  • International Cancer Research Technology Transfer (ICRETT) by the International Union Against Cancer - Four weeks training at the Fred Hutchinson Cancer Research Centre, USA in bone marrow transplantation procedures and medical oncology, 1981
     

Past Experience

  • Chief of Medical Oncology Sushrut Hospital
  • Chief of Medical Oncology Jaslok Hospital
  • Chief of Medical Oncology Nanavati Hospital
  • Chief of Medical Oncology SL Raheja Hospital
  • Chief of Medical Oncology HN Reliance Hospital
  • Medical Oncologist Hiranandani Hospital
  • Director, Department of Medical Oncology, Jaslok Hospital & Research Centre. 
  • Professor and Chief, Department of Medical Oncology. Tata Memorial Hospital.2002
  • Medical Oncologist at Breach Candy Hospital, Mumbai, India
  • Medical Oncologist at Raheja Hospital, Mumbai, India
  • Medical Oncologist at Fortis Hospital Mulund Hospital, Mumbai, India
  • Medical Oncologist, Tata Memorial Hospital 1985
  • Assistant Medical Oncologist, Tata Memorial Hospital. 1980

Awards

  • “PADMA BHUSHAN” by Government of India (2012)
  • The Baroda Sun Life Time Achievement Award.Bank of Baroda (2008)
  • Dr. Ch. Gnaneswar Memorial Oration Award (2008).
  • Dr. B.C. Roy National Award. Medical Council of India (2005)
  • Nazli Gad-el-Mawla Award (2005). INCTR
  • Lifetime Achievement in Oncology (2005) Harvard Medical International
  • Gifted Teacher Award (2004) The Association of Physicians of India.
  • Dr. M.A. Panawala Oration ( 2003) Indian Medical Association, North East Bombay Suburban Branch.
  • Dr. K.M. Bhansali Memorial Oration Award (2003)
  • Dr. D.K. Gosavi Oration Award (2003)
  • Dhanvantari Award (2002)
  • PHO Oration Award (2002)
  • “PADMASHRI” by Government of India (2002)
  • Dr. M.S. Ramakrishnan Memorial Endowment Oration Award (2002)
  • Dr. H.M. Bhatia Memorial Oration Award Institute of Immunohematology, ICMR, KEM Hospital, Parel, Mumbai (2001)
  • Dr. B.L. Agarwal Memorial Oration Award Indian Medical Association, Allahabad Branch, Allahabad (2001)
  • Sahyog Foundation Award Sahyog Foundation, Mumbai (2000)
  • Dr. Bankat Chandra Memorial Oration (Certificate of Appreciation) Indian Medical Association, Hyderabad City (2000)
  • Award of Fellowship of (ISHTM) Indian Society of Hematology & Transfusion Medicine, Mumbai (2000)
  • Dr. V.S. Bhende Oration Award Mahim Dharavi Medical Practitioners Association, Mumbai (2000)
  • Sir Dorab Tata Memorial Trust Oration Award ISO conference, New Delhi (1999)
  • “GIANT INTERNATIONAL AWARD” GIANTS INTERNATIONAL, Mumbai (1998)
  • Dr. Jal Patel Memorial Oration Award Governing Council of the Research Society, Grant Medical College and Sir J.J. Group of Hospitals, Mumbai (1998)
  • Indo-American Cancer Congress Inc. Award of Excellence Philadelphia. PA (1996)
  • Wanker Oration Award Indian Medical Association, Nagpur (1996)
  • Dr S S Thakur Conference Oration Bombay Obstetric and Gynaecological Society (1995)
  • Annual Oration of Indian Association for Cancer Research Indian Cancer Research Society (1994)
  • "Sandoz Oration Award" Indian Council of Medical Research (ICMR) (1994.)
  • Dayalal Vadalia Memorial Cancer Oration Rajkot Cancer Society (1993)
  • Dr. J. B. Chatterjee Memorial Oration Award Chittaranjan Cancer Hospital (1991)
  • Dr J.G. Parekh Oration Award Bombay Haematology Group (1990)
  • Blood Group Reference Centre (BGRC) Silver Jubilee Oration Award Indian Council of Medical Research (1990)
  • Manorama Sapre Oration Award Indian Society of Haematology and Blood Transfusion (1985)
  • UNICHEM Lectureship in Hematology Association of Physicians of India (1983)

Associations/Membership

  • President, Indian Society of Oncology, 1999-2000
  • President, Medical and Pediatric Oncology Society from 1991-1994
  • Secretary, Indian Journal of Haematology and Blood Transfusion 1986-1988
  • Member, Editorial Board of Journal of Association of Physicians of India (API)
  • Editor, Indian Journal of Haematology & Blood Transfusion since 1993
  • President, Indian Society of Medical & Pediatric Oncology (1991-1995)
  • Member, Editorial Board of Pediatric Haematology Oncology since 1993. (Published from Norway).
  • Recognized Teacher from M.Sc and Ph.D (Applied Biology) of the University of Bombay.
  • Recognized Teacher for DM in Medical Oncology at the University of Bombay.
  • Examiner for DM (Medical Oncology) of Madras, Bangalore and Gujarat University.
  • Member, Indian Advisory Committee -Lady Tata Memorial Trust.
  • Member, Editorial Board of Indian Journal of Experimental Biology.
  • Honorary Editor, Asian Cancer: Published by Excerpta Medica Hong Kong.
  • Member, Editorial Board of Cancer, Research Therapy and Control. (G & B Editorial Services, Inc)
  • Member, Editorial Board of ?ONCOSPHERE? (Communicore)
  • Member, Editorial Board of Cancer, Research Therapy and Control. (G & B Editorial Services, Inc.)
  • Member, Editorial Board of ?ONCOLOGY FORUM? An Asian Journal of Cancer Care, Hong Kong, representing India.
  • member of the Indian Society of Organ Transplantation, Membership no. LM 445 Sanjay Gandhi Postgraduate Institute of Medical Science Raebareli, Lucknow, 226 014, INDIA.
  • Member, Indian Cancer Registry( ICMR)
  • Member, Managing Committee, Mahavir Sthan Nyas Samiti, Patna.
  • Advisor, Advisory Council of ?Asian Journal of Cancer?
     

Paper Published

He has published over 654 research articles and papers. Some of them are:

  • AN Bhisey, SGA Rao & SH Advani. Alterations in electrophoretic mobility of mouse macrophage treated with microtubule inhibitors. Ind. J. Expt. Biol. 15: 970-972, 1972.
  • VR Joshi, SH Advani, MA Ahmed. Abnormal precordial pulsation. Maharashtra Med. Journal 20; 107, 1973.
  • GS Sainani, SJ Shah, VR Joshi, SH Advani. Sick sinus syndrome.Ind. Heart Journal 25; 178, 1973.
  • SH Advani, MA Ahmed, VR Joshi. Aneurysm of sinus of Valsalva. J. Indian Med. Association 65: 154, 1975.
  • GS Sainani, VR Joshi, SH Advani, UL Wagholikar. Myocardial abscess. Ind. Heart Journal 27; 66, 1975.
  • SH Advani. Advances in chronic myeloid leukemia therapy. Maharashtra Med. Jour. XXIII; 279, 1975.
  • Advani SH. Letter: Acute myeloid leukemia with Burkitt’s tumor cells. Blood. Dec: 46 (6)990-2, 1975.
  • AG Khare, AN Bhisey, SH Advani, KJ Ranadive. Cytogenetic studies in myeloproliferative disorders. Proceeding of a symposium on structural & functional aspect of chromosome 25-26; 241, 1975.
  • JS Nadkarni, JJ Nadkarni, SS Ranade, RS Chougule, SR Kasturi, SH Advani. In vitro studies on human leukemic cells by pulsed nuclear magnetic resonance, compared with membrane-specific immunofluorescence reactivity. Indian Journal of Cancer 13; 76-80, 1976.
  • SH Advani, GV Talwalkar, JS Nadkarni, JJ Nadkarni, SM Sirsat,U Srinivasan.Hairy cell leukemia. Ind.J.Cancer 13; 283-287, 1976.
  • BP Gothoskar, H. D'silva, H. Gharpure, SH Advani. Leucocyte migration studies in chronic myeloid leukemia (CML) specificity of reaction. Europ. J. Cancer 12; 815-821, 1976.
  • SG Gangal, BP Gothoskar, CS Joshi, SH Advani. Demonstration of cellular immunity in chronic myeloid leukemia using leucocyte migration inhibition assay: Brit. J. Cancer 33; 267-272, 1976.
  • Sastry PSRK, Advani S.H.; Inhalational GM-CSF to reduce pulmonary morbidity in Bone Marrow Cell Transplantation. Bulletin of the Jaslok Hospital & Research Centre, 2003.
  • P.S.R.K. Sastry, Anjana Sainani, S.H. Advani: Thrombotic Complications of Anti angiogenic Therapy – a case report. Bulletin of the Jaslok Hospital & Research Centre, Vol. XXVII No. 4, 2003
  • S. Somjee, S.K. Pai, S.H. Advani: Evolution of chemotherapy in Osteosarcoma; I.J.M.P.O. Vol. 22 No. 3,4.
  • Suresh H. Advani, Chetna A Bakshi, Ashish V Bakshi: Breast Cancer Management: Role of Chemotherapy; JIMSA April-June 2003Vol. 16 No.2
  • Somjee S, Jindal R, Advani SH: Benign multilocular cystic nephroma. Indian J Pediatr. 2003 Jun;70(6):515-7
  • Siraj AK, Kamat S, Gutierrez MI, Banavali S, Timpson G, Sazawal S, Bhargava M, Advani S, Adde M, Magrath I, Bhatia K. Frequencies of the significant subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West. Leukemia,2003 Jun;17(6):1192-3.
  • Das M, Saikia TK, Advani SH, Parikh PM, Tawde S.: Use of a reduced-intensity conditioning regimen for allogeneic transplantation in patients with chronic myeloid leukemia. Bone Marrow Transplant. 2003 Jul;32(2):125-9.
  • Amare PS, Pais A, Nair C, Banavali S, Advani SH: Translocation (8;20), a variant of t(8;21), in T-acute lymphoblastic leukemia: a first report. Cancer Genet Cytogenet. 2003 Aug: 145 (1):88-90.
  • K Ansari, A Clerk, MH Patel, Anjana Sainani, PSRK Sastry, SH Advani: Hypercalcemia Induced by parathyroid hormone-related peptide after treatment of squamous cell carcinoma of the oral cavity—case report. JAPI, Vol 51, October 2003; 1023-1024.
  • Chetna Bakshi, Shripad Banavali, Nilesh Lokeshwar, Rajendra Prasad, Suresh Advani: Clustering of Fournier (Male Genital) Gangrene Cases in a Pediatric Cancer Ward. MPO. 10110 page 472-474.
  • Chetna Bakshi, Pratibha Amare (Kadam), Dhiraj Abhyankar, Chanda Baisane, Shripad Banavali, Suresh Advani: Chromosomal Rearrangement in Down Syndrome with Acute Myeloid Leukemia. Indian Journal of Pediatrics, Vol. 70- September, 2003; 755-758.
  • Reetu Jain, S.H. Advani, A. Sainani, Chetna Bakshi, P.S.R.K. Sastry, Caspofungin – The first Echinocandin antifungal drug. Bulletin of the Jaslok Hospital & Research Centre, Vol. XXVIII No. 2, 2003;33-37
  • Unmesh Mohite, Mayukh Das, Tapan Saikia, Purvish Parikh, R. Gopal, R. Kelkar and Suresh Advani. Mycobacterial Pulmonary Infection Post Allogeneic Bone Marrow Transplantation. Leukemia and Lymphoma, 2001. Vol. 40(5-6), pp. 675-678
  • Metkar SS, Manna PP, Anand M, Naresh KN, Advani SH, Nadkarni JJ. CD 40 Ligand-an anti-apoptotic molecule in Hodgkin’s Disease. Cancer BiotherRadiopharm. 2001 Feb:16(1):85-92.
  • Amare Kadam PS, Varghese C, Bharde SH, Narasimhamoorthy NK, Desai S,Advani SH, Havaldar R, Kulkarni JN. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.Cancer Genet Cytogenet. 2001 Mar;125(2):139-46.
  • Arya S, Dhond S, Shinde S, Badrinath Y, Mahadik S, Sapre R, Kumar A, Chougule A, Ansari R, Nair C, Advani S.H. Splenic Lymphoma with Villous Lymphocytes a Laboratory Review of Six Cases Indian Journal of Hematology & Blood Transfusion, Volume XIX No.2, June 2001. P-31
  • D Abhyankar, Swati Bajpai, T Saikia, R Gopal, C N Nair, S H Advani 2CdA in the Treatment of Hairy Cell Leukemia JAPI, Vol. 49, pp 785-787, August 2001.
  • D. Abhyankar, T. Saikia and S. Advani Gynecomastia in a Case of Hairy Cell Leukemia – Cladribine Induced? Leukemia and Lymphoma, 2001, Vol. 42(1-2), pp. 243-246.
  • Agarwal P., Ranjan S., Sharma L., Nikam A., Parikh P., Saikia T., Advani S., Gemtuzumab Ozogamicin (Mylotarg) – Drug Review Indian J. Hemat & Blood Transf. 2001; Vol. 19: No. 3; 74-75.
  • B B Yeole, S.H. Advani and Lizzy Sunny. Epidemiological features of childhood cancers in Greater Mumbai Journal of the Indian Academy of Pediatrics, Indian Pediatrics-2001, Vol. 38, November 2001, pp 1270-76.
  • Saikia TK, Menon H, Advani SH. Prolonged neutropenia following anti-CD20 therapy in a patient with relapsed follicular non-Hodgkin’s Lymphoma and corrected with IVIG. Ann Oncol. 2001 Oct; 12(10):1493-4.
  • P.S. Amare, C. Baisane, T. Saikia, R. Nair, H. Gawade, S. Advani.Fluorescence in situ hybridization: a highly efficient molecular diagnosis and prediction technique for disease course in patients with myeloid leukemias.Cancer Genetics and Cytogenetics 1131(2001), 125-134.
  • B BYeole, A P Kurkure, S.H. Advani, Sunny Lizzy An Assessment of Cancer Incidence Patterns in Parsi and Non-Parsi Populations, Greater Mumbai. Asian Pacific Journal of Cancer Prevention, Vol 2, 2001;2(4):293-298.
  • Abhyankar D, Menon H, Saikia T, Advani S. Rhinocerebral Mucormycosis infection in Multiple Myeloma: A Case Report Indian Journal of Hematology & Blood Transfusion, pp. 97, December 2001.
  • Jyoti Kode, Suresh Advani and Shubhada Chiplunkar. T-cell receptor and  Gene Rearrangements in T-cell Acute Lymphoblastic Leukemia in Indian Patients. Leukemia and Lymphoma 2000, Jan;36(3-4)331-8.
  • K.N. Naresh, J. Johnson, V. Srinivas, CS Soman, T. Saikia, S.H. Advani,R.A. Badwe, K.A. Dinshaw, M. Muckadem, I. Magrath, and K. Bhatia. Epstein-Barr virus association in classical Hodgkin’s Disease provides a survival advantage to patients and correlates with higher expression of proliferation markers in Reed-STe—Sternberg cells. Annals of Oncology 11, 91-96: 2000.
  • Y. Nerurkar, P. Vijayan, V. Srinivas, C.S. Soman, K.A. Dinshaw, S.H.Advani, I. Magrath, K. Bhatia and K.N. Naresh. Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin’s disease: Impact on pathogenesis. Annals of Oncology 11: (4):475-8: 2000.
  • Dhiraj Abhyankar, Reena Nair, Hari Menon, Bhupendra Kapoor and Suresh Advani. Avascular Necrosis of Head of Femur in a Patient with Acute Promyelocytic Leukemia. Leukemia and Lymphoma 37(5):635-637, 2000.
  • Abhyankar D and Advani SH. Cladribine (Drug Review) Background and Drug Development. Indian J. Hemat & Blood Tranf 18(1):19-21, 2000.
  • Mohite U, Das M., Parikh PM, Saikia TK, Gopal R, Mohite M, Todankar H and Advani SH. Cyclosporine Associated Fever in a Patient Undergoing Allogeneic Bone Marrow Transplantation. Ind. J. of Heamt. & Bl. Transf. 18(1):11, 2000.
  • Letter to Editor, Kulkarni K. Reply : Parikh PM, Hiwase DK, Pai VR, Gopal R, Saikia TK and Advani SH. Indian J. of Hemat. & Blood Transf. 18(1):22-23,2000.
  • Nishigandha Naik, Jean-Paul Rigaut, Suresh Advani and Avinash Bhisey: Differences in the microtubule organization between normal and CMLgranulocytes after stimulation with chemotactic peptide. Cell Biology International 24, (3) 135-144, 2000
  • V.Radhika, N.R. Naik, S.H. Advani and A.N. Bhisey Actin Polymerization in Response to Different Chemoattractants is Reduced in Granulocytes from Chronic Myeloid Leukemia Patients Cytometry (communications in clinical Cytometry) 42:379-386(2000)
  • D. Abhyankar, Chetna Shende, T. Saikia, S. Advani Hydroxyurea Induced Leg Ulcers JAPI 2000, Vol. 48, No.9, PP 926-927.
  • D. Abhyankar, T. Saikia & S. Advani Gynecomastia in a Case of Hairy Cell Leukemia - Cladribine Induced. Leukemia and Lymphoma,2000, Vol. 7, pp 1-4.
  • Bapna A., Abhyankar D., Amare(Kadam)P., Gladstone B., Advani S. Relapse with Acute Myeloblastic Leukemia(M2) in Acute Promyelocytic Leukemia(M3): A Case Report Indian J. Hemat & Blood Transf. 2000; Vol. 18: No. 3;, 60-61
  • D. Abhyankar, B Kapoor and S.H. Advani Newer Strategies in HematoOncology. API- Assam Chapter, Medicine Millenium Update-2000. P. 186-203, Vol. No. 1, 2000.
  • D.K. Hiwase, A. Mukhopadhyay, P.M. Parikh, R. Gopal T.K. Saikia, V.R. Pai, S.S. Menon & S.H. Advani Ceftazidime and Netilmicin Versus Ceftazidime and Amikacin for Febrile Neutropenia. Indian Journal of Medical & Pediatric Oncology, Vol 21 No. 1, March 2000 pp 21-27.
  • Giles FJ, Shan J, Chen S, Advani SH, Supandiman I, Aziz Z, Caviles AP, Tee GY, Chasen MR, Fahed Z, Chao TY, Aydogdu I, Lynott AM. A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the international Oncology Study Group CML1 study. Leuk Lymphoma 2000 Apr;37(3-4):367-77.
  • Arati Rao, N.A. Jambhekar, Chandrika N Nair, R.K. Deshpande, S.C. Pande, S.H. Advani. Undifferentiated (Embryonal) sarcoma of the Liver. Indian Journal of Medical & Pediatric Oncology, Vol 21 No.2, June 2000 pp 48-50.
  • Rathore VB, Advani SH, Nadkarni JJ. A high cytosolic pool of p75 TNF receptors and delayed surface-down modulation by mononuclear cells from non-Hodgkin’s lymphoma patients. Cytokine 2000 Jul;12(7):1142-6.
  • Metkar SS, Naresh KN, Manna PP, Srinivas V, Advani SH, Nadkarni JJ. Circulating levels of TNF alpha and TNF receptor superfamily members in lymphoid neoplasia. Am J Hematol. 2000 Oct;65(2):105-10.
  • Giles FJ, Shan J, Advani SH, Akan H, Aydogdul I, Aziz Z, Azim HA, Bapsy PP, Buyckkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid HM, Itragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S: International Oncology Study Group NHL 1 Study. A prospective randomized study of CHOP versus CHOP plus Alpha-2B Interferonin patients with intermediate and high-grade Non-Hodgkin’s Lymphoma: theInternational Oncology Study Group NHL 1 Study. Leuk Lymphoma 2000 Dec:40(1-2)95-103.
  • Limited Efficacy of ticarcillin-clavulanic acid and amikacin in the empiric treatment of febrile neutropenia in children with hematolymphoid malignancies. Anupama Broker, Indumati Ambulkar, Nilesh Lokeshwar, R Gopal, SH Advani Indian Pediatrics, February 2008.
  • Patkar N, Mehta J, Kulkarni B, Pande R, Advani S, Borges A: Immunoprofile of Hodgkin’s Lymphoma in India. Indian Jurnal of Cancer, April –June 2008; volume 45, issue 2: 59-63. 

Field of Expertise

  • Adrenal Cancer Treatment
  • Benign and Cancerous Tumor Excision
  • Bile Duct Cancer Treatment
  • Brain Tumor Surgery
  • Breast Biopsy
  • CAR T-Cell Therapy
  • Carcinoid Tumor Treatment
  • Castleman Disease Treatment
  • Chemotherapy
  • Colon Cancer Surgery
  • Completion Thyroidectomy
  • D2 Gastrectomy
  • Endometrial Biopsy
  • Endometrial Cancer Treatment
  • Endoscopic Tumor Removal
  • Ewing Family of Tumors Treatment
  • Fine Needle Aspiration
  • Genitourinary Cancer Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Hormone Therapy
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Image-Guided Radiation Therapy (IGRT)
  • Immunotherapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Kaposi Sarcoma Treatment
  • Lobectomy
  • Lumpectomy
  • Malignant Mesothelioma Treatment
  • Metastatic Tumor Treatment
  • Microsurgical Tumor Removal
  • Minimally Invasive Cancer Surgery
  • Mohs Surgery
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Oncological Surgery
  • Ovarian Biopsy
  • Pap Smear
  • Papillary Thyroid Cancer Treatment
  • Penile Cancer Treatment
  • PET CT Scan
  • Proton Therapy
  • Radiation Therapy
  • Radioisotope Therapy
  • Rhabdomyosarcoma (RMS) Treatment
  • Robotic Cancer Surgery
  • Skin Lymphoma Treatment
  • Small Intestine Cancer Treatment
  • Targeted Therapy
  • Thymectomy
  • Thymoma and Thymic Carcinoma Treatment
  • Transarterial Chemoembolization (TACE)
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Whipple Procedure
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia (AML)
  • Acute Promyelocytic Leukemia (APL)
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • Adnexal Tumor
  • Adrenocortical Carcinoma
  • Adult Hodgkins Lymphoma
  • AIDS-Related Cancer
  • Ameloblastoma
  • Anal Cancer
  • Anaplastic Carcinoma
  • Appendix Cancer
  • Astrocytoma
  • Atypical Hyperplasia
  • Atypical Spindle Cell Tumor
  • Atypical Teratoid/Rhabdoid Tumor (ATRT)
  • Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
  • Basal Cell Carcinoma (BCC)
  • Basal Cell Carcinoma of the Skin
  • Benign Bone Tumors
  • Benign Hematology
  • Benign Lung Tumors
  • Benign Soft Tissue Tumors
  • Bile Duct Cancer, Stones, & Strictures
  • Blood Cancer
  • Bone Cancer
  • Bone Marrow Cancer
  • Brain Stem Glioma
  • Breast Cancer
  • Breast Cancer During Pregnancy
  • Breast Cancer Recurrence
  • Bronchial Tumors
  • Burkitt Lymphoma
  • Cancer in Children
  • Carcinoid Syndrome
  • Carcinoid Tumor (Gastrointestinal)
  • Carcinoid Tumors of the Lungs
  • Cervical Cancer
  • Childhood Acute Lymphoblastic Leukemia
  • Cholangiocarcinoma
  • Chordomas
  • Chronic Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelogenous Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Chronic Myeloproliferative Neoplasms
  • Colorectal Cancer
  • Cutaneous T-Cell Lymphoma
  • Cyclic Neutropenia
  • Desmoid Tumor
  • Ductal Carcinoma in Situ (DCIS)
  • Elevated PSA (Prostate-Specific Antigen) Level
  • Embryonal Tumors
  • Eosinophilia
  • Esophageal Cancer
  • Esophagectomy
  • Esthesioneuroblastoma
  • Estrogen Dependent Cancers
  • Ewing Sarcoma
  • Extracranial Germ Cell Tumor
  • Extragonadal Germ Cell Tumor
  • Extrahepatic Bile Duct Cancer
  • Fallopian Tube Cancer
  • Familial Adenomatous Polyposis (FAP)
  • Familial Adenomatous Polyposis (FAP): Inherited
  • Fanconi Anemia (FA)
  • Follicular Lymphoma
  • Free Flap Surgery for Treating Osteoradionecrosis
  • Gallbladder Cancer
  • Gangrene
  • Gastric Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Gestational Trophoblastic Disease
  • Giant Cell Tumor
  • Gliomas Tumors
  • Gum Tumor
  • Hairy Cell Leukemia (HCL)
  • Head and Neck Cancer
  • Heart Cancer
  • Hemangiopericytoma
  • Hemophilia
  • Hepatocellular Cancer
  • Hereditary Non-polyposis Colorectal Cancer (HNPCC)
  • Hodgkin Lymphoma
  • Hurthle Cell Carcinoma
  • Hypopharyngeal Cancer
  • Hypopharyngeal Cancer
  • Immunotherapy
  • In-situ Breast Cancer
  • Incontinence After Prostate Surgery
  • Inflammatory Breast Cancer
  • Intensity Modulated Radiation Therapy
  • Intraocular Melanoma
  • Invasive Breast Cancer
  • Invasive Lobular Carcinoma
  • Islet Cell Tumor
  • Kaposi Sarcoma
  • Kidney Cancer
  • Langerhans Cell Histiocytosis (LHC)
  • Large Cell Carcinoma
  • Large Granular Lymphocytic (LGL) leukemia
  • Laryngeal Cancer
  • Leukemia
  • Lip and Oral Cavity Cancer
  • Liver Cancer
  • Liver Cysts & Liver Tumors
  • Lung Cancer
  • Lymphatic Cancer
  • Lymphedema
  • Lymphocytosis
  • Male Breast Cancer
  • Malignant Fibrous Histiocytoma (MFH)
  • Malignant Mesothelioma
  • Malignant Peripheral Nerve Sheath Tumor (MPNST)
  • Malignant Soft Tissue Tumors
  • Mediastinal Teratoma
  • Mediastinal Tumor
  • Medullary Carcinoma
  • Medulloblastoma
  • Melanoma
  • Meningioma
  • Merkel Cell Carcinoma
  • Metastatic Cancer
  • Metastatic Spinal Tumors
  • Metastatic Squamous Neck Cancer with Occult Primary
  • Metastatic Tumors
  • Mouth Cancer
  • Multiple Endocrine Neoplasia (MEN) Syndromes
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Nasal Cancer
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Angiofibroma
  • Nasopharyngeal Cancer
  • Neuroendocrine Tumor
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • NUT Midline Carcinoma
  • Olfactory Neuroblastoma
  • Oncogenic Osteomalacia
  • Ophthalmic Cancer
  • Optic Nerve Glioma
  • Oral Cancer
  • Oropharyngeal Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Ovarian Germ Cell Tumors
  • Ovarian Primary Peritoneal Cancer
  • Ovarian Sex Cord Stromal Tumor
  • Pancreatic Cancer
  • Pancreatic Neuroendocrine Tumor
  • Paraganglioma
  • Paranasal Tumor
  • Paraneoplastic Syndromes
  • Parathyroid Cancer
  • Parotid Gland Tumor
  • Pediatric Chordomas
  • Pediatric Ependymoma
  • Pediatric Germ Cell Tumor
  • Pediatric Rhabdomyosarcoma
  • Pediatric Spinal Cord Tumor
  • Pediatric Spinal Tumor
  • Pediatric Vascular Tumors
  • Penile Cancer
  • Pharyngeal Cancer
  • Pheochromocytoma
  • Pigmented Villonodular Synovitis (PVNS)
  • Pineal Region Tumor
  • Plasma Cell Neoplasms
  • Pleural Tumor
  • Pleuropulmonary Blastoma
  • Polycythemia Vera
  • Primary Central Nervous System (CNS) Lymphoma
  • Prostate Cancer
  • PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
  • Pulmonary Nodules
  • Pure Red Cell Aplasia (PRCA)
  • Rectal Cancer
  • Recurrent Cancer
  • Relapsed ALL
  • Relapsed AML
  • Relapsed Multiple Myeloma
  • Renal Cell Cancer
  • Retinoblastoma (Cancer of the Eye)
  • Retroperitoneal Tumor
  • Rhabdomyosarcoma
  • Sacrococcygeal Teratoma (SCT)
  • Salivary Gland Cancer
  • Sarcoma
  • Sezary Syndrome
  • Sickle Cell Anemia
  • Skin Cancer
  • Skull Base Tumor
  • Small Cell Carcinoma
  • Small Cell Lung Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Spinal Tumor
  • Squamous Cell Carcinoma (SCC)
  • Stage 4 Cancer
  • Stomach Cancer
  • Sun Exposure & Skin Cancer
  • Synovial Sarcoma
  • Tarlov Cysts
  • Testicular Cancer
  • Throat Cancer
  • Thrombocytosis
  • Thymoma and Thymic Carcinoma
  • Thymus Gland Tumor
  • Thyroid Cancer
  • Tracheobronchial Tumor
  • Transitional Cell Cancer
  • Urethral Cancer
  • Uterine Cancer
  • Uterine Sarcoma
  • Vaginal Cancer
  • Vascular Tumor
  • Vulvar Cancer
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor